4 results match your criteria: "China. heartcenter@163.com.[Affiliation]"
Highlights of the 2024 Chinese hypertension guidelines.
Hypertens Res
January 2025
Department of Hypertension, Peking University People's Hospital, Beijing, China.
The 2024 Chinese hypertension guidelines has been recently issued by Chinese Hypertension League (CHL), joint with partner societies. Since the 2018 guidelines was released, amount of evidence accumulated, in favor of intensive blood pressure (BP) control. New drugs and devices, innovative concepts and new insights have been introduced into hypertension management.
View Article and Find Full Text PDFKnowledge gap and prescribing patterns of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors among Chinese doctors.
Sci Rep
August 2024
Center for Clinical and Epidemiologic Research, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Article Synopsis
- * A survey of 358 doctors showed only 30-40% had a good understanding of these medications, with tertiary hospital doctors being more knowledgeable.
- * Major barriers to prescribing include high costs, concerns about side effects, and a lack of sufficient knowledge, highlighting the need for better education and resources for doctors.
Effect of orlistat-assisted weight loss on endothelium-dependent vasodilation in obese Chinese subjects with hypertension.
Clin Exp Hypertens
March 2011
Heart Center, Peking University People's Hospital, Beijing, China.
The present study aims to evaluate the effects of orlistat-assisted weight loss on endothelium-dependent vasodilation by ultrasonography in obese Chinese subjects with hypertension. Thirty obese hypertensive patients (mean age: 46.6 +/- 10.
View Article and Find Full Text PDFTo compare the effects of losartan and atenolol on plasma fibrinolytic parameters and von Willebrand factor (vWF), Chinese subjects with mild-to-moderate hypertension were randomized to receive losartan (50 mg/day; n = 30) or atenolol (50 mg/day; n = 30) for 8 weeks. If target blood pressure (< 140/90 mmHg) was not achieved at week 4, hydrochlorothiazide (12.5 mg/day) was also administered.
View Article and Find Full Text PDF